HBIO Harvard Bioscience Inc.

Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018

Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018

HOLLISTON, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting its new neuroscience products and applications for preclinical life science research at Neuroscience 2018, the 48th annual meeting of the Society for Neuroscience (SfN) in San Diego on November 3-7.

“With all three of our commercial units participating in this event, customers and researchers will be able to see the full scope of Harvard Bioscience’s expertise in neuroscience. We will have team members on hand from our Ephys, DSI and PCMI businesses, sharing their expertise through symposiums, poster presentations and product demonstrations,” said Jeffrey Duchemin, President and CEO of Harvard Bioscience. “We look forward to this event with great anticipation and excitement as we help our customers advance their work in neuroscience research.”

Scientific and Educational Events Highlight Impact of Harvard Bioscience Research Solutions

• Five speakers from prestigious academic research centers will share their wireless in vivo neural recording and stimulation research using Multi Channel Systems and Triangle Biosystems International’s technology in the symposium “Wireless in vivo Neural Recording & Stimulation,” on Monday, November 5 from 6:30 PM to 8:30 PM in the San Diego Convention Center, Room 2. For more information:

• Highlights of Triangle BioSystems’ (TBSI) development progress with high channel count recording, electrical and optogenetic stimulation, and implantable capsule technology will be presented in a poster “High Channel Count Wireless Neural Recording and Stimulation for in vivo Electrophysiology for Non-Human Primates” (Poster #172.01/III39) on Sunday, November 4 from 8:00 AM to 9:00 AM. The abstract can be found here:

• Research utilizing Data Sciences International telemetry tools are highlighted in several posters:

  • “Pharmacological activation of superior colliculus and periaqueductal gray alters physiological measures of arousal” (Saturday, November 3 from 1:00 PM -2:00 PM, (Poster #070.13/TT6)
  • “Preclinical global electroencephalography and seizure characterization in an Angelman syndrome mouse model” (Sunday, November 4 from 11:00 AM -12:00 PM, Poster #119.16/D41)
  • “The NMDAr positive allosteric modulator CAD-8688 reverses mismatch negativity impairments in the rat sub-chronic PCP model of schizophrenia” (Sunday, November 4, 2:00-3:00 PM, Poster #252.10/III28)
  • “Optimizing a mouse model of severe nerve agent intoxication for long-term survivability, incidence of neuropathology, and emergence of spontaneous recurrent seizures” (Tuesday, November 6, 4:00-5:00 PM, Poster #560.04/F1).

• A poster illustrating the use of the ECM 830 for in vivo delivery of CRISPR gene editing constructs to the brain will be available for review at the Physiology, Cell and Molecular Instruments (PCMI) booth #2829.

Harvard Bioscience Comprehensive Suite of Neurology Tools Featured

Innovative products from Harvard Bioscience’s three commercial units—Electrophysiology (Ephys), Data Sciences International (DSI) and Physiology, Cell and Molecular Instruments (PCMI)—will be at Booths # 2813, #1920 and #2829, respectively.

Electrophysiology (Ephys) – Booth #2813

Ephys is exhibiting its new combined Smart Ephys in vivo wireless system, which enables the use of lightweight and reliable headstages from Triangle BioSystems (TBSI) with cutting-edge Multi Channel Systems (MCS) data acquisition and software. Additional new products include a 32-channel micro preamplifier offering a smaller, more cost-effective headstage option for recordings not requiring stimulation that wish to retain the advantages of MCS’s tethered in vivo ME2100-System and the next generation of valve control systems from Warner Instruments with a 7” touch screen for even easier operation and control.

More information can be found here:

Data Sciences International (DSI) – Booth #1920

DSI will be displaying new implants for neuroscience that enable the continuous collection of up to four biopotential channels (typically EEG and EMG), plus temperature and activity for use in research areas such as sleep, seizure, affective disorders, movement disorders and neurodegenerative disorders. New implants for continuous glucose measurement will also be presented that allow the collection of stress-free data, with fewer blood draws and fewer animals. The implants are now available for mice, rats and large animals. In addition, DSI will be available to discuss video-EEG for enhancing neuroscience research. Video-EEG animal models allow researchers to better understand neuronal activity as well as diagnose and develop pharmaceutical drugs. DSI offers solutions for collecting and analyzing Video-EEG data including hardwired systems, implantable telemetry, video cameras and software.

More information can be found here:

Physiology, Cell and Molecular Instruments (PCMI) – Booth #2829

BTX is showing solutions to advance all aspects of life science research from electroporation and electrofusion equipment to micro-volume spectrophotometers to the most accurate pen-sized pipettors and everything in between. New this year is the ECM 830 Mammalian Transfection System, a multifunctional square wave electroporation generator that is ideal for delivery of molecules of interest into mammalian cells and tissues with high transfection efficiencies, including difficult-to-transfect cell types such as stem cells and primary cells. It has a well-established publication record, including CRISPR gene editing technologies. The booth will also show other tools from Biochrom, Hoefer, Coulbourn Instruments, Panlab and CMA.

More information can be found here:

About Harvard Bioscience

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of solutions to advance life science. Our products are sold to thousands of researchers in over 100 countries through our global sales organization, websites, catalogs, and through distributors including Thermo Fisher Scientific Inc., VWR, and other specialized distributors. We have sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Italy, Canada and China. For more information, please visit our website at .

Contact:

Corey Manchester

Corporate Controller

Tel: 508 893 8999

Media Contact:

DGI Comm

Cheryl Schneider

212-825-3210

EN
02/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Harvard Bioscience Inc.

 PRESS RELEASE

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Resu...

Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to high-single-digit EBITDA growth in 2026Outlines strategy focused on positioning the company as a leader in the growing translational science tools market while expanding consumables revenue and improving operational performance HOLLISTON, Mass.,...

 PRESS RELEASE

Harvard Bioscience Announces Strategic Consolidation of Manufacturing ...

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to deliver approximately $3 million in cost savings in 2027 and $4 million in annual cost savings beginning in 2028 while improving throughput and execution HOLLISTON, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today announced a strategic conso...

 PRESS RELEASE

Harvard Bioscience Announces the Successful Completion of Debt Refinan...

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial FlexibilityBroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities  HOLLISTON, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today announced it entered into an agreement with BroadOak Capital Partners (collectively, “BroadOak”), a...

 PRESS RELEASE

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Harvard Bioscience Announces Third Quarter 2025 Financial Results Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by OperationsCompany Expects to Refinance or Repay the Debt in the Fourth QuarterFourth Quarter 2025 Guidance Reflects Increased Demand and Backlog, Improved Operations and Strong Financial Discipline HOLLISTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2025. “Our third-quarter performance hig...

 PRESS RELEASE

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Ca...

Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.  Participants who would like to join the call and ask a question must register . Once registered, you will receive the dial-in numbers and a unique PIN number.  Participants who would like...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch